BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38453527)

  • 1. Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development.
    Yang D; Hu Y; Yang J; Tao L; Su Y; Wu Y; Yao Y; Wang S; Ye S; Xu T
    J Pharmacol Exp Ther; 2024 Apr; 389(2):163-173. PubMed ID: 38453527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases.
    Wu YC; Yao Y; Tao LS; Wang SX; Hu Y; Li LY; Hu S; Meng X; Yang DS; Li H; Xu T
    Cell Signal; 2023 Feb; 102():110550. PubMed ID: 36464104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
    Abe H; Aida Y; Seki N; Sugita T; Tomita Y; Nagano T; Itagaki M; Sutoh S; Nagatsuma K; Itoh K; Matsuura T; Aizawa Y
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1376-83. PubMed ID: 25778454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
    Seo W; Gao Y; He Y; Sun J; Xu H; Feng D; Park SH; Cho YE; Guillot A; Ren T; Wu R; Wang J; Kim SJ; Hwang S; Liangpunsakul S; Yang Y; Niu J; Gao B
    J Hepatol; 2019 Nov; 71(5):1000-1011. PubMed ID: 31279903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway.
    Xia P; Liu DH; Wang D; Wen GM; Zhao ZY
    Free Radic Biol Med; 2023 Sep; 206():125-133. PubMed ID: 37406742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Gene Polymorphisms, Metabolic Activity, and Content of Alcohol Dehydrogenase and Acetaldehyde Dehydrogenases on Prognosis of Hepatocellular Carcinoma Patients.
    Gao N; Chen J; Qi B; Zhao T; Guo Y; Fang Y; Han Z; Qiao HL
    Turk J Gastroenterol; 2022 Jul; 33(7):606-614. PubMed ID: 35879918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-671-5p Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma through Targeting ALDH2.
    Chen X; Luo J; Gao S; Jiang J; Yang B; Zhang Z
    Crit Rev Eukaryot Gene Expr; 2022; 32(4):73-82. PubMed ID: 35695667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis.
    Jin S; Chen J; Chen L; Histen G; Lin Z; Gross S; Hixon J; Chen Y; Kung C; Chen Y; Fu Y; Lu Y; Lin H; Cai X; Yang H; Cairns RA; Dorsch M; Su SM; Biller S; Mak TW; Cang Y
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9088-93. PubMed ID: 26150517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population.
    Sakamoto T; Hara M; Higaki Y; Ichiba M; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Tanaka K
    Int J Cancer; 2006 Mar; 118(6):1501-7. PubMed ID: 16187278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
    Zhou D; Xiao L; Zhang Y; Xian J; Jiang J; Zong W; Huang Z; Yang Y
    Tumour Biol; 2012 Jun; 33(3):841-6. PubMed ID: 22231434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a Chinese population.
    Ding J; Li S; Wu J; Gao C; Zhou J; Cao H; Su PS; Liu Y; Zhou X; Chang J
    Asian Pac J Cancer Prev; 2008; 9(1):31-5. PubMed ID: 18439068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
    Hou G; Chen L; Liu G; Li L; Yang Y; Yan HX; Zhang HL; Tang J; Yang YC; Lin X; Chen X; Luo GJ; Zhu Y; Tang S; Zhang J; Liu H; Gu Q; Zhao LH; Li Y; Liu L; Zhou W; Wang H
    Hepatology; 2017 May; 65(5):1628-1644. PubMed ID: 28027570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma].
    Ye X; Peng T; Liu T; Su Z; Xiao K; Shang L; Su M; Li L
    Wei Sheng Yan Jiu; 2010 Jan; 39(1):42-5. PubMed ID: 20364586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
    Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
    J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma.
    Liu ZY; Lin XH; Guo HY; Shi X; Zhang DY; Sun JL; Zhang GC; Xu RC; Wang F; Yu XN; Wang D; Weng SQ; Shen XZ; Liu TT; Dong L; Zhu JM
    Int J Biol Sci; 2024; 20(7):2763-2778. PubMed ID: 38725845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism.
    Kato S; Tajiri T; Matsukura N; Matsuda N; Taniai N; Mamada H; Yoshida H; Kiyam T; Naito Z
    Scand J Gastroenterol; 2003 Aug; 38(8):886-93. PubMed ID: 12940444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformed ALDH2
    Zhang XN; Meng FG; Wang YR; Liu SX; Zeng T
    Med Hypotheses; 2021 Jan; 146():110366. PubMed ID: 33208242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of ALDH2 rs671 and CYP2E1 rs2031920 with hepatocellular carcinoma susceptibility in East Asians: a meta-analysis.
    Chen J; Pan W; Chen Y; Wen L; Tu J; Liu K
    World J Surg Oncol; 2020 Jan; 18(1):21. PubMed ID: 31987047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells.
    Sanchez AC; Li C; Andrews B; Asenjo JA; Samulski RJ
    Hum Gene Ther; 2017 Sep; 28(9):717-725. PubMed ID: 28578603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aldehyde dehydrogenase with hepatocellular carcinoma].
    Wang WJ; Gao YH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):475-478. PubMed ID: 32660174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.